对用于乳腺癌患者含内乳淋巴结照射的稳健混合计划技术的回顾性评估
该研究回顾性分析本机构2016至2020年217例接受混合放疗技术(两个IMRT切线野加两个部分VMAT野)的乳腺癌患者剂量学与放射生物学数据,并评估乳腺肿胀0.4至1.5 cm时的稳健性,与纯VMAT技术对比。混合计划在肿胀1.5 cm时PTVEval D95%从96.1%降至92.1%,纯VMAT从94.3%降至87%。混合技术对危及器官保护良好,散射剂量高于纯VMAT但低于纯IMRT。
要点
- 混合技术由两个IMRT切线野和两个部分VMAT野组成,用于乳腺癌含内乳淋巴结照射。
- 乳腺肿胀1.5 cm时PTVEval D95%混合计划从96.1%降至92.1%,纯VMAT从94.3%降至87%。
- 混合技术散射剂量高于纯VMAT、低于纯IMRT,源于MU数更高和适形度更低。
核心结论
- 本放疗科采用该技术治疗大量患者,表明所提计划技术可行。
- 回顾性分析显示混合放疗技术对危及器官保护良好,且对乳腺肿胀至1.5 cm具有稳健性。
- 混合技术散射剂量略高于纯VMAT技术,源于MU数更高和适形度更低。
研究设计与样本
- 回顾性剂量学与放射生物学分析本机构2016至2020年217例患者治疗数据(右侧和左侧)。
- 对随机选取的一例患者评估乳腺人工肿胀0.4至1.5 cm时的稳健性,并与使用虚拟bolus的纯VMAT计划技术比较。
- 对选定患者计划计算野外杂散剂量并与替代放疗技术比较。
主要发现
- 乳腺肿胀1.5 cm时,混合计划PTVEval D95%从96.1%降至92.1%处方剂量,纯VMAT计划从94.3%降至87%。
- 217例患者回顾性剂量学评估显示全肺Dmean 6.5 ± 0.9 Gy(NTCP[Semenenko 2008] 2.8 ± 0.5%)。
- 患侧肺Dmean 10.9 ± 1.5 Gy,对侧肺Dmean 2.2 ± 0.6 Gy。
- 心脏Dmean 2.1 ± 1.1 Gy(ERR[Schneider 2017] 0.02 ± 0.17%),对侧乳腺Dmean 1.7 ± 0.6 Gy。
- 混合放疗技术散射剂量高于纯VMAT、低于纯IMRT照射。
临床怎么用
- 本研究中心的做法是采用由两个IMRT切线野和两个部分VMAT野组成的混合放疗技术治疗含内乳淋巴结的乳腺癌患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The irradiation of breast cancer patients with included internal mammary lymph nodes challenges radiation planning with regard to robustness and protection of OARs. In this publication, a feasible hybrid radiation technique is presented with a retrospective dosimetric and radiobiological analysis of patient data of our institute from 2016 to 2020 and robustness analysis. METHODS: The proposed hybrid irradiation technique consists of two IMRT tangents and two partial VMAT fields. The retrospective dosimetric and radiobiological evaluation are made for 217 patient treatments (right- and left-sided). The robustness is evaluated regarding an artificial swelling from 0.4 to 1.5 cm for a random example patient and compared to a pure VMAT planning technique with use of a virtual bolus. The out of field stray dose is calculated for a selected patient plan and compared to alternative radiation techniques. RESULTS: The coverage D95% of the PTVEval (with breast swelling of 1.5 cm) changes for the hybrid plan from 96.1 to 92.1% of prescribed dose and for the pure VMAT plan from 94.3 to 87%. The retrospective dosimetric evaluation of patient irradiations reveals a Dmean for total lung 6.5 ± 0.9 Gy (NTCP[Semenenko 2008] 2.8 ± 0.5%), ipsilateral lung 10.9 ± 1.5 Gy, contralateral lung 2.2 ± 0.6 Gy, heart 2.1 ± 1.1 Gy (ERR[Schneider 2017] 0.02 ± 0.17%) and contralateral breast 1.7 ± 0.6 Gy. The scatter dose of the hybrid irradiation technique is higher than for pure VMAT and lower than for pure IMRT irradiation. CONCLUSIONS: The feasibility of the proposed planning technique is shown by treating many patients with this technique at our radiotherapy department. The hybrid radiation technique shows a good sparing of the OARs in the retrospective analysis and is robust with regards to a breast swelling of up to 1.5 cm. The slightly higher stray dose of the hybrid technique compared to a pure VMAT technique originates from higher number of MUs and lower conformity.
引用
- Hennet M, Radonic S, Schneider U, et al. Retrospective evaluation of a robust hybrid planning technique established for irradiation of breast cancer patients with included mammary internal lymph nodes. Radiat Oncol. 2022. PMID: 35428265. doi:10.1186/s13014-022-02039-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。